Table 3.
β | R 2 | p | |
---|---|---|---|
Assumed Sleep/CA | |||
Autism | 0.26 | 0.07 | 0.79 |
FASD | −0.15 | 0.02 | 0.10 |
TD | 0 | <0.01 | 0.72 |
Sleep Duration/CA | |||
Autism | −0.33 | 0.11 | 0.14 |
FASD | −0.14 | 0.02 | 0.49 |
TD | −0.02 | <0.01 | 0.91 |
Sleep Efficiency/CA | |||
Autism | 0.11 | 0.01 | 0.69 |
FASD | −0.16 | 0.03 | 0.43 |
TD | 0.02 | <0.01 | 0.89 |
Sleep Latency/CA | |||
Autism | −0.22 | 0.05 | 0.42 |
FASD | 0.07 | 0.01 | 0.72 |
TD | 0.01 | <0.01 | 0.93 |
Fragmentation/CA | |||
Autism | −0.07 | 0.01 | 0.79 |
FASD | 0.21 | 0.04 | 0.31 |
TD | 0.06 | <0.01 | 0.72 |
Highlighted results: β absolute value of >0.2 indicates a slight but not significant trend, whilst < 0.05 indicates a constant or no developmental trend. CA—chronological age. Significant results shown in bold.